MedTrace Logo

Development and Validation of MPF to Prevent and Mitigate Postural Hyperkyphosis in Postmenopausal Women

NCT07068360 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-07-16

No results posted yet for this study

Summary

Postural hyperkyphosis is common in postmenopausal women and leads to spinal dysfunction, pain, impaired balance, and increased fall risk. This study aims to develop and validate a multimodal physiotherapy framework to prevent and manage hyperkyphosis in this population. A randomized controlled trial will be conducted at Allied Hospital with 72 postmenopausal women aged 40-75 years, divided into intervention (multimodal physiotherapy with conventional care) and control (conventional care only) groups.

Conditions

  • Hyperkyphosis

Interventions

COMBINATION_PRODUCT

Strength Training +Postural Correction Exercises + Balance Training +Flexibility Exercises

Interventions details (Group A) Strength Training Postural Correction Exercises Balance Training Exercises Flexibility Exercises:

DIAGNOSTIC_TEST

Standard Intervention (Control Group)

The control group will receive standard physiotherapy for postural hyperkyphosis. The standard intervention will consist of: Postural education: Educating participants on proper posture, body mechanics, and ergonomics in daily activities. Basic stretching exercises targeting the thoracic spine and back muscles. Recommendations for low-impact aerobics activities (e.g., walking or cycling) to promote overall healthThe standard intervention will be delivered over the same 12-week period, with two sessions per week. This group will not receive the integrated multimodal framework with strength training, postural correction, balance training, and flexibility exercises that the experimental group receives. Duration and Frequency

Sponsors & Collaborators

  • Superior University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-17
Primary Completion
2025-12-01
Completion
2026-06-01

Countries

  • Pakistan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07068360 on ClinicalTrials.gov